West Pharmaceutical Services

West delivers innovative solutions to improve the safe delivery of pharmaceutical, health care and personal care products and is the world’s premier manufacturer of components and systems for injectable drug delivery. We serve the world’s leading pharmaceutical and biopharmaceutical companies. Pharmaceutical, biopharmaceutical and medical device companies around the world rely on West Pharmaceutical Services, Inc. for standard-setting systems and device components for parenterally administered medicines. West applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer health care products. West Analytical Services applies decades of pharmaceutical industry drug product testing, development and packaging expertise to assist customers through the complex laboratory analysis associated with meeting drug product, stability, container closure and packaging regulatory guidelines. West’s professionals provide expertise to customers from early product development through full production. Our expertise helps mitigate risk, implement world-class production technologies and comply with global regulatory requirements. West has made substantial investments in products, processes and plants that will add value for customers now and in the future. The Tech Group, a West company, is a global leader in injection molding offering contract manufacturing solutions for pharmaceutical delivery systems, medical devices and personal care and consumer products. Medimop Medical Projects Ltd., a West company, is a leader in the world market for transfer, mixing and administration systems for injectable pharmaceuticals. Founded in 1923 with global headquarters in Lionville, Pennsylvania, West has a presence in North America, South America, Asia/Pacific, Middle East and Europe and 6,300 employees worldwide. The West name means assured top quality to the leaders of the global pharmaceutical industry. Customers rely on West’s packaging systems and components for safety, efficiency, reliability and leading-edge technologies that improve drug administration. Shares of West’s common stock are traded on the New York Stock Exchange under the symbol WST.
Company Growth (employees)
Exton, US
Size (employees)
7,300 (est)
West Pharmaceutical Services was founded in 1923 and is headquartered in Exton, US

West Pharmaceutical Services Office Locations

West Pharmaceutical Services has an office in Exton
Exton, US (HQ)
530 Herman O. W Dr

West Pharmaceutical Services Financials and Metrics

West Pharmaceutical Services Financials

West Pharmaceutical Services's revenue was reported to be $1.5 b in FY, 2016

Revenue (Q3, 2017)

398.2 m

Net income (Q3, 2017)

51 m

EBIT (Q3, 2017)

63.9 m

Market capitalization (13-Dec-2017)

7.5 b

Cash (30-Sep-2017)

269.3 m


7.4 b
West Pharmaceutical Services's current market capitalization is $7.5 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


1.4 b1.4 b1.4 b1.5 b

Revenue growth, %


R&D expense

36.8 m

General and administrative expense

239.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


341.8 m346.8 m368.9 m355.9 m335.9 m359.7 m344.5 m362.1 m388 m376.7 m387.7 m397.6 m398.2 m

R&D expense

9.6 m10 m9.9 m9.6 m7.5 m8.1 m8.5 m9.4 m8.8 m9 m10.3 m10 m9.1 m

General and administrative expense

56.1 m56.4 m57.5 m56 m55.2 m60.8 m54.6 m58.1 m62.5 m58.3 m61.6 m60.6 m61.5 m

Operating expense total

65.7 m66.4 m67.4 m65.6 m62.7 m68.9 m63.1 m67.5 m71.3 m67.3 m71.9 m70.6 m70.6 m
USDFY, 2013FY, 2014FY, 2015FY, 2016


230 m255.3 m274.6 m203 m

Accounts Receivable

185.7 m179 m181.4 m200.5 m


176.9 m181.5 m181.1 m199.3 m

Current Assets

650.7 m659.3 m673.7 m641.9 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


221.7 m230 m226.7 m246.8 m207.1 m252 m256.8 m178.1 m202.7 m205.9 m169.4 m226.6 m269.3 m

Accounts Receivable

198.2 m208.7 m209.6 m195.9 m189.5 m198.8 m194.6 m209.6 m219 m209.5 m224.8 m242.4 m251.8 m


176.7 m187.5 m187.9 m185.7 m183.4 m187.2 m187.7 m194.1 m197.7 m201.1 m212.3 m211.3 m215.8 m

Current Assets

643.5 m686.6 m685.4 m679.5 m625.1 m679.9 m680.9 m630.7 m659.2 m658.1 m652.6 m717.8 m776.9 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

112.3 m127.1 m95.6 m143.6 m

Depreciation and Amortization

81 m84.8 m86.1 m88.1 m

Accounts Receivable

(9.1 m)(6.3 m)(14 m)(23.3 m)


(14 m)(16 m)(11 m)(21.2 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

26.8 m27.1 m37.6 m31 m32.9 m60.7 m62.2 m22.1 m66.9 m104.5 m60.9 m99.7 m150.7 m

Accounts Receivable

198.8 m194.6 m209.6 m219 m209.5 m224.8 m


187.2 m187.7 m194.1 m197.7 m201.1 m212.3 m

Accounts Payable

91.4 m93.6 m97.5 m107.3 m99 m106.1 m
USDY, 2017


116.1 x


54.5 k

Financial Leverage

1.5 x
Show all financial metrics

West Pharmaceutical Services Market Value History

West Pharmaceutical Services Median Salaries

Source: 17 public H-1B filings from West Pharmaceutical Services

West Pharmaceutical Services's Web-traffic and Trends

West Pharmaceutical Services Online and Social Media Presence

West Pharmaceutical Services Company Life and Culture

You may also be interested in